Biotransformation of lovastatin
- 2 November 1991
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 290 (2) , 355-361
- https://doi.org/10.1016/0003-9861(91)90551-s
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991
- Biotransformation of lovastatin—IIIBiochemical Pharmacology, 1990
- Physiological Disposition of Hmg-Coa-Reductase InhibitorsDrug Metabolism Reviews, 1990
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemiaClinical Pharmacology & Therapeutics, 1986
- Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or .beta.-naphthoflavoneBiochemistry, 1982
- The effects of mevinolin on serum cholesterol levels of rabbits with endogenous hypercholesterolemiaAtherosclerosis, 1982
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982